Search

ISSN: 2228-5881 eISSN: 2251-7308

2024, Vol 14, No. 3

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. A Combination of Prebiotic Inulin and Oligofructose Improve Some of Cardiovascular Disease Risk Factors in Women with Type 2 Diabetes: A Randomized Controlled Clinical Trial

Akbar Aliasgharzadeh, Mohammad Khalili, Elham Mirtaheri, Bahram Pourghassem Gargari, Farnaz Tavakoli, Mahdieh Abbasalizad Farhangi, Hossein Babaei, Parvin Dehghan*

Adv Pharm Bull. 2015;5(4): 507-514. doi: 10.15171/apb.2015.069

PMCID: PMC4729356 PMID: 26819923 Scopus ID: 84949661490

Article

PDF

XML

Cited By:

52

22

66

Short Communication

2. GLP 1 Regulated Intestinal Cell’s Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes

Shivani Srivastava , Harsh Pandey, Surya Kumar Singh, Yamini Bhusan Tripathi*

Adv Pharm Bull. 2019;9(2): 325-330. doi: 10.15171/apb.2019.039

PMCID: PMC6664108 PMID: 31380261 Scopus ID: 85068574199

Article

PDF

XML

Cited By:

1

1

4

Research Article

3. Type 2 Diabetes Mellitus Provokes Rat Immune Cells Recruitment into the Pulmonary Niche by Up-regulation of Endothelial Adhesion Molecules

Eghbal Zarafshan , Reza Rahbarghazi , Jafar Rezaie, Mohammad Reza Aslani, Shirin Saberianpour, Mahdi Ahmadi* , Rana Keyhanmanesh

Adv Pharm Bull. 2022;12(1): 176-182. doi: 10.34172/apb.2022.019

PMCID: PMC9012922 PMID: 35517882 Scopus ID: 85125521292

Article

PDF

Suppl 1

Full Text

XML

Cited By:

2

1

2

Research Article

4. Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α

Raziye Tajali , Akram Eidi, Hosein Ahmadi Tafti, Abdolreza Pazouki, Ali Mohammad Sharifi*

Adv Pharm Bull. 2023;13(2): 350-360. doi: 10.34172/apb.2023.021

PMCID: PMC10278222 PMID: 37342375

Article

PDF

Full Text

XML

Cited By:

0

2

Editorial

5. Exploring a Synergistic Approach: Dual GLP-1 Agonist Combined with Degludec Basal Insulin for Early Type 1 Diabetes Treatment and its Impact on Albumin-Insulin Producing Cells Expression

Amr Ahmed , Maher Monir. Akl*

Adv Pharm Bull. 2024;14(2): 262-265. doi: 10.34172/apb.2024.040

PMCID: PMC11347740 PMID: 39206389

Article

PDF

XML

Cited By:

0

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank